https://www.selleckchem.com/products/pk11007.html
Moreover, we discuss various parameters to consider for designing optimized and best-suited PET radioligands.Chronic kidney disease (CKD) is a global health problem with a prevalence of 10-15%. Progressive fibrosis of the renal tissue is a main feature of CKD, but current treatment strategies are relatively unspecific and delay, but do not prevent, CKD. Exploration of novel pharmacological targets to inhibit fibrosis development are therefore important. Transglutaminase 2 (TG2) is known to be central for extracellular collagenous matrix
Like
Comment
Share
